Notice of New Investment in Cloverna
Keio Innovation Initiative (KII) has invested in Cloverna, an RNA drug discovery bio-venture company, from a fund managed by KII. Through this capital increase, Cloverna will raise a total of 100 million yen to accelerate the expansion of its business.
For more details, please see the press release.
https://prtimes.jp/main/html/rd/p/000000034.000018580.html